FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne-Marie Duliege

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Drug Administration Schedule

Procedures

Physiology

Antibody Formation

Living Beings

HIV-1

Co-author Network

Publications

TOP 3
Iain C Macdougall; Steven Fishbane; Anne-Marie Duliege
Peginesatide for anemia in chronic kidney disease.
Iain C Macdougall; Martha R Mayo; Pablo E Pergola; Krishna R Polu; Robert Provenzano; Rebecca J Schmidt; Amit Sharma; Bruce S Spinowitz; Hong Tang; Sandra Tong-Starksen; Raja I Zabaneh; Anne-Marie Duliege; Steven Fishbane
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
Steven Fishbane; Carol Francisco; Mark Kaplan; Nathan W Levin; Francesco Locatelli; Iain C Macdougall; Martha R Mayo; Krishna R Polu; Robert Provenzano; Brigitte Schiller; Andrzej Wiecek; Anatole Besarab; Adrian C Covic; Anne-Marie Duliege
Peginesatide in patients with anemia undergoing hemodialysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne-Marie Duliege (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Iain C Macdougall; Steven Fishbane; Anne-Marie Duliege
Peginesatide for anemia in chronic kidney disease.
The New England journal of medicine 2013;368(16):1553-4.
2013: Iain C Macdougall; Martha R Mayo; Pablo E Pergola; Krishna R Polu; Robert Provenzano; Rebecca J Schmidt; Amit Sharma; Bruce S Spinowitz; Hong Tang; Sandra Tong-Starksen; Raja I Zabaneh; Anne-Marie Duliege; Steven Fishbane
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
The New England journal of medicine 2013;368(4):320-32.
2013: Steven Fishbane; Carol Francisco; Mark Kaplan; Nathan W Levin; Francesco Locatelli; Iain C Macdougall; Martha R Mayo; Krishna R Polu; Robert Provenzano; Brigitte Schiller; Andrzej Wiecek; Anatole Besarab; Adrian C Covic; Anne-Marie Duliege
Peginesatide in patients with anemia undergoing hemodialysis.
The New England journal of medicine 2013;368(4):307-19.
2012: Anatole Besarab; Carol A Francisco; Edouard R Martin; Martha Mayo; Pablo E Pergola; Krishna R Polu; Brigitte Schiller; Frederick C Whittier; Raja I Zabaneh; Steven N Zeig; Anne-Marie Duliege
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.
BMC nephrology 2012;13():95.
2011: Iain C Macdougall; Iain MacPhee; Martha Mayo; Ashraf Mikhail; Michal Mysliwiec; Michal Nowicki; Krishna R Polu; Peter J Schatz; Olgierd Smolenski; Wladyslaw Sulowicz; Beatriz Tucker; Andrzej Wiecek; Magdi Yaqoob; Carol Francisco; Anne-Marie Duliege
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(11):2579-86.
2009: Iain C Macdougall; Jérôme Rossert; Nicole Casadevall; Richard B Stead; Anne-Marie Duliege; Marc Froissart; Kai-Uwe Eckardt
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
The New England journal of medicine 2009;361(19):1848-55.
2008: Sukyung Woo; Wojciech Krzyzanski; Anne-Marie Duliege; Richard B Stead; William J Jusko
Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers.
Journal of clinical pharmacology 2008;48(1):43-52.
2007: Ronald T Mitsuyasu; Rebecca Gelman; Deborah Weng Cherng; Alan Landay; John Fahey; Richard Reichman; Alejo Erice; R Pat Bucy; J. Michael Kilby; Michael M Lederman; Carol D Hamilton; Juan Lertora; Becky L White; Pablo Tebas; Anne-Marie Duliege; Richard B Pollard
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
Archives of internal medicine 2007;167(6):597-605.
2006: Richard B Stead; John Lambert; Dawie Wessels; Julie S Iwashita; Kerstin K Leuther; Kathryn W Woodburn; Peter J Schatz; Douglas M Okamoto; Robert Naso; Anne-Marie Duliege
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.
Blood 2006;108(6):1830-4.
2003: Jerome H Kim; Punnee Pitisuttithum; Chirasak Kamboonruang; Thippawan Chuenchitra; John R Mascola; Sarah Schlesinger Frankel; Mark de Souza; Victoria R Polonis; Robert McLinden; Anna Sambor; Arthur E Brown; Benjaluck Phonrat; Kittipong Rungruengthanakit; Anne-Marie Duliege; Merlin L Robb; John McNeil; Deborah L Birx
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
AIDS research and human retroviruses 2003;19(9):807-16.
2003: Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria R Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.
The Journal of infectious diseases 2003;188(2):219-27.
2003: Alberdina W de Boer; Norman Markowitz; H Clifford Lane; Louis D Saravolatz; Susan L Koletar; Haig Donabedian; Carl Yoshizawa; Anne-Marie Duliege; Gwendolyn Fyfe; Ronald T Mitsuyasu
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells.
Clinical immunology (Orlando, Fla.) 2003;106(3):188-96.
2002: David I Bernstein; Mark R Schleiss; Klara Berencsi; Eva Gonczol; Michelle Dickey; Philip R Khoury; Michel Cadoz; Claude Meric; John Zahradnik; Anne-Marie Duliege; Stanley Plotkin
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
The Journal of infectious diseases 2002;185(5):686-90.
2002: Douglas K Mitchell; Sandra J Holmes; Rae Lynn Burke; Anne-Marie Duliege; Stuart P Adler
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers.
The Pediatric infectious disease journal 2002;21(2):133-8.
2000: Richard Davey; Robert L Murphy; F M Graziano; SL Boswell; Andrew T Pavia; M Cancio; J P Nadler; Doreen G Chaitt; Robin L Dewar; D K Sahner; Anne-Marie Duliege; W B Capra; W P Leong; M A Giedlin; H Clifford Lane; J O Kahn
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.
JAMA : the journal of the American Medical Association 2000;284(2):183-9.
2000: Sorachai Nitayaphan; Chirasak Khamboonruang; N Sirisophana; Patricia Morgan; Joseph Chiu; Anne-Marie Duliege; Cheodchai Chuenchitra; T Supapongse; Kittipong Rungruengthanakit; Mark de Souza; John R Mascola; K Boggio; Silvia Ratto-Kim; Lauri E Markowitz; Deborah L Birx; Vinai Suriyanon; John G McNeil; Arthur E Brown; Rodney A Michael
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.
Vaccine 2000;18(15):1448-55.